BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Neurodevice Firm Checkpoint Surgical Raises $3 Million


1/27/2012 8:56:19 AM

CLEVELAND, Jan. 27, 2012 /PRNewswire/ -- Neurodevice firm Checkpoint Surgical completed a $1.7 million Series B investment round led by the NDI Healthcare Fund in December 2011, and secured non-dilutive funding of over $1.3 million, including a $1.065 million Innovation Ohio loan and a $245,000 federal grant.

(Logo: http://photos.prnewswire.com/prnh/20120127/DC43077LOGO)

Checkpoint Surgical was founded in 2009 in Cleveland, Ohio. In 2010, the company launched its flagship product, the CHECKPOINT® Stimulator/Locator, the first in a line of neuroprotective surgical devices. The CHECKPOINT® Stimulator/Locator is a state-of-the-art hand-held, intraoperative nerve and muscle stimulator that helps surgeons to locate, identify and evaluate nerves during surgery to facilitate nerve preservation and repair.

"Over the past year, the CHECKPOINT® has demonstrated market acceptance and is used in a wide range of nerve repair, ENT, orthopaedic, plastic reconstructive, and oncological surgical procedures at many of the nation's premier hospitals," said Len Cosentino, CEO and president of Checkpoint Surgical. "We've enjoyed consistent quarterly sales growth since launching the CHECKPOINT® and more than 250% growth in 2011 over 2010."

Checkpoint Surgical is using the funding to support its sales and marketing efforts and new product development. The company distributes its products in the U.S. through a combination of direct sales and distributors.

For more information, please visit www.checkpointsurgical.com.

About Checkpoint Surgical
Founded in 2009, Checkpoint Surgical's mission is to provide surgeons with state-of-the-art neurodevices to preserve nerves and evaluate nerve and muscle excitability in surgical procedures for better patient outcomes. In 2010, Checkpoint Surgical launched the CHECKPOINT® Stimulator/Locator as its flagship product in a line of proprietary neuromuscular surgical devices. For more information, visit www.checkpointsurgical.com

About NDI Healthcare Fund
Founded in 2010, the NDI Healthcare Fund is a leading venture capital and commercialization firm that focuses on innovative neurodevice technologies to address significant unmet health conditions, improve patients' lives and provide significant returns to investors. NDI is headquartered in Cleveland, Ohio with locations in North Carolina's Research Triangle and Minneapolis, Minnesota. For more information, visit www.ndimedical.com

SOURCE Checkpoint Surgical



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES